|
|
Previous Article | Table of Contents | Next Article 
Migration of cells with immunoglobulin/c-myc recombinations in lymphoid
tissues of mice
JR Muller, GM Jones, S Janz and M Potter
Laboratory of Genetics, National Cancer Institute, National Institutes of
Health, Bethesda, MD 20892-4255, USA.
Recombinations between c-myc and immunoglobulin (Ig) sequences that
typically occur in pristane-induced mouse plasmacytomas were detected in
secondary lymphoid tissues from normal mice, chiefly in the gut- associated
lymphoid tissue. Based on the analysis of recombination sequences as
clonotypic markers, migration of c-myc recombination- positive cells was
observed between Peyer's patches and into the intestine. Treatment of
plasmacytoma-susceptible BALB/cAn mice with pristane induced proliferation
and migration of these cells into mesenteric lymph node, spleen, and oil
granuloma within 7 days. Plasmacytoma-resistant strains of mice (DBA/2N,
C3H/HeJ, C57BL/6) differed in that (1) they harbored fewer clones (Ig/c-myc
recombinations were detected in 33% of resistant mice versus 91% of
BALB/cAn mice after pristane treatment); (2) Ig/c-myc-positive cells were
rarely detected in the oil granuloma, and (3) c-myc recombined
predominantly with the Ig alpha locus in BALB/cAn mice (72%), but with the
Ig mu locus in DBA/2N and in C57BL/6 (67%). The results demonstrate that
normal mice generate a large number of lymphocytes with aberrant c- myc in
intestinal tissues without developing tumors.
Volume 89,
Issue 1,
pp. 291-296,
01/01/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Janz
Genetic and Environmental Cofactors of Myc Translocations in Plasma Cell Tumor Development in Mice
J Natl Cancer Inst Monographs,
July 1, 2008;
2008(39):
37 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Park, J. S. Kim, L. Tessarollo, J. D. Owens, L. Peng, S. S. Han, S. Tae Chung, T. A. Torrey, W. C. Cheung, R. D. Polakiewicz, et al.
Insertion of c-Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice
Cancer Res.,
February 15, 2005;
65(4):
1306 - 1315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Silva, A. L. Kovalchuk, J. S. Kim, G. Klein, and S. Janz
BCL2 Accelerates Inflammation-induced BALB/c Plasmacytomas and Promotes Novel Tumors with Coexisting T(12;15) and T(6;15) Translocations
Cancer Res.,
December 15, 2003;
63(24):
8656 - 8663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Felix, K. A. Kelliher, G.-W. Bornkamm, and S. Janz
Elevated Mutant Frequencies in Lymphoid Tissues Persist throughout Plasmacytoma Development in BALB/c.{{lambda}}LIZ Mice
Cancer Res.,
August 1, 1999;
59(15):
3621 - 3626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Amoroso, N. Huang, A. B. Roberts, M. Potter, and J. J. Letterio
Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas
PNAS,
January 6, 1998;
95(1):
189 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|